Global Fiducial Markers Market
Fiducial markers are objects placed in a strategic way to visualize it in an imaging system’s visual representation. These markers are metal objects placed close to a tumor for preparing the patient during a radiation therapy helping physicians use it as a reference point. This helps in isolation of the cancerous cell and focusing the dosage of therapy on that particular area helping to reduce the damage caused towards the surrounding tissue.
Access Full Report at https://www.databridgemarketresearch.com/reports/global-fiducial-markers-market
The main factors behind the growth of the market are:
- Rising adoption of radiotherapy devices by oncologists: Due to the effectiveness of radiotherapy in treatment of various types of cancer, large volume of oncologists has initiated their adoption. This trend of utilizing radiotherapy as an effective therapeutic method is subsequently positively effecting the growth of associated devices and components required for its success. Therefore, the market for fiducial markers is experiencing a positive growth trend as radiotherapy requires better isolation and identification methods so that physicians can target a particular area of the patient’s body to focus on, i.e. where the tumor is present
- Increasing cases of cancer worldwide: Another major factor that is boosting the levels of growth associated with fiducial markers is the volume of patients suffering from cancer globally. This has positively impacted the demands for fiducial markers, as they are highly effective in providing better diagnostics for physicians which subsequently helps in enhancing the mode of treatment. These devices are also used in some specific methods of cancer treatment, such as radiotherapy
The market is segmented on the basis of type as polymer-based markers, metal-based markers, others; modality as CT/CBCT, cyberknife, linac, magnetic resonance imaging, proton therapy, tomotherapy; disease site as head & neck, breast, lung, abdomen, prostate, kidney, cervix, other; application as hospitals, radiotherapy, cancer research institutes, others.
Some of the key market developments are as follows:
- In 2017, 59th Annual Meeting & Exhibition of American Association of Physicists in Medicine (AAPM) 2017 was organized in Denver, Colorado, United States held from July 30-August 3, 2017. One of the programs of this exhibition was identifying the purpose of fiducial markers in radiotherapy visualization for cone-beam CT projections and pseudo-4D topograms
- In October 2015, Medtronic announced the launch of “superDimension Lung Navigation Software” capable of suggesting fiducial marker placements. This innovation will provide diagnostic users with better preparation and information regarding the lung cancer therapy system for patients. This innovation suggest the focus of Medtronic’s strategy to expand their capabilities for lung-related health products and solutions
“According to Data Bridge Market Research, global fiducial markers market is expected to be growing at a substantial CAGR during the forecast period of 2019 to 2026”
Some of the major players operating in the market are Eckert & Ziegler, Boston Scientific Corporation, IBA, Best Medical International, Inc., IZI Medical Products, Carbon Medical Technologies, CIVCO Radiotherapy, Stellar Medical, goldanchormarker.com, Koninklijke Philips N.V., Veran Medical Technologies, MRIequip.com, Medtronic, Hologic, Inc, JJ-MEDTECH among others.
One of the major opportunities available with the market players of fiducial markers is the benefits associated with the usage of fiducial markers in diagnostic procedures for cancer. Their usage even helps in better treatment of cancer as it can help physicians isolate the areas to focus on during the different procedural systems.
